Yearly Trends of Overactive Bladder Medication Usage.

Author: ChuaKevin J, DoppalapudiSai Krishnaraya, HyamsElias, PatelHiren V, SrivastavaArnav, TabakinAlexandra, TunuguntlaHari S G R

Paper Details 
Original Abstract of the Article :
Anticholinergics are associated with cognitive side effects and dementia. Agents such as trospium, fesoterodine and darifenacin have been shown to be less likely to cross the blood-brain barrier. Furthermore, in 2012, mirabegron was approved by the U.S. Food and Drug Administration as the first beta...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1097/UPJ.0000000000000243

データ提供:米国国立医学図書館(NLM)

Overactive Bladder Medication: A Shifting Landscape

The desert of medical research is constantly evolving, and this research explores the evolving landscape of overactive bladder (OAB) medication usage. This study examines the prescribing patterns of OAB medications in the United States over time, revealing the dynamic nature of medical practice. This study is like a time traveler’s journal, documenting the changes in medical trends and practices. The authors investigate the usage of various OAB medications, including anticholinergics and mirabegron, a beta-3 adrenoreceptor agonist. This research highlights the changing understanding of OAB and its treatment, emphasizing the importance of ongoing research and evaluation of medication effectiveness and safety.

Evolving Treatment Options for OAB

The research suggests that there has been a shift in the prescribing patterns of OAB medications, with a growing preference for newer agents like mirabegron, which are associated with fewer cognitive side effects. This is like a caravan of travelers adapting its route to avoid treacherous terrain, seeking safer and more effective paths. The study also highlights the importance of considering potential side effects, particularly cognitive impairment, when prescribing OAB medications. This is like recognizing the hidden dangers in the desert, ensuring that travelers are equipped to navigate the terrain safely.

Navigating the Desert of OAB Treatment

This research provides valuable insights into the changing landscape of OAB treatment. It underscores the importance of staying informed about the latest research and treatment options, ensuring that patients receive the most appropriate and effective care. This is like a desert explorer constantly updating their map, staying informed about the latest discoveries and challenges in the ever-changing terrain.

Dr.Camel’s Conclusion

This research offers a glimpse into the dynamic world of OAB treatment, highlighting the importance of ongoing research and adaptation to new knowledge and insights. Like a desert caravan navigating a shifting landscape, we must continually adjust our approach to ensure the best possible care for patients with OAB.
Date :
  1. Date Completed n.d.
  2. Date Revised 2023-05-07
Further Info :

Pubmed ID

37145398

DOI: Digital Object Identifier

10.1097/UPJ.0000000000000243

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.